| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Allovir, Inc. | Director | Common Stock | 3,164,954 | $2,123,051 | $0.6708 | 25 May 2021 | Indirect |
| Allovir, Inc. | Director | Stock Option (Right to Buy) | 22,500 | 25 May 2021 | Direct | ||
| Marker Therapeutics, Inc. | Director | Stock Option (right to buy) | 8,000 | 06 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MRKR | Marker Therapeutics, Inc. | 06 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 21:33 |
| MRKR | Marker Therapeutics, Inc. | 24 May 2022 | 1 | $0 | 4 | Director | 26 May 2022, 16:12 |
| MRKR | Marker Therapeutics, Inc. | 08 Jun 2021 | 1 | $0 | 4 | Director | 10 Jun 2021, 18:53 |
| KLRS | Allovir, Inc. | 25 May 2021 | 1 | $0 | 4 | Director | 27 May 2021, 16:50 |